Definitive Contract 75F40124C00083
Award Date
7/24/24
Potential Completion Date
3/12/28
Potential Value
$699K
Federal Agency
Food and Drug Administration
Awardee
Duke University
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
Duke University has been awarded a firm fixed price purchase order totaling $22,137 by the Department of Health and Human Services Food and Drug Administration. The contract is for technical expertise in predictive toxicology for drug-induced liver injury to be delivered through April 2025 in Durham, North Carolina. As the prime contractor, Duke University will provide technical expert services through its Office of Research Administration to support the FDA's predictive toxicology programs....
This federal contract award to Duke University, valued at $748,779.00, was issued by the Food and Drug Administration (FDA) to perform a targeted review of literature regarding the quality of life of patients with overactive bladder (OAB) and the use of the Lower Urinary Tract Symptom Score-Interstitial Cystitis-10 (LURN SI-10) measure. The contract also requires eliciting the relative importance of LURN SI-10 items from the patients' perspective using a preference-elicitation instrument. This...
Duke University, a private non-profit educational institution, was awarded a $13,082,628.82 federal contract by an unspecified government agency to provide Biomedical (Applied/Exploratory) services. The contract, which does not have a set-aside designation, is a Definitive Contract with a Cost No Fee pricing type. The period of performance runs from the award date of September 15, 1996 through the completion date of February 28, 2005. The place of performance is Durham, North Carolina. Duke...
The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
This federal contract award was made by the National Institute of Child Health and Human Development, a civilian agency, to Duke University as the prime contractor. The $236,068.40 fixed-price cost contract is for biomedical research and exploratory studies, with a performance period ending on June 30, 2013. Duke University is a private, non-profit educational institution that has extensive experience delivering a wide range of research and development services to federal agencies through both...
Duke University is the prime contractor on a $1,609,333 cost-no-fee definitive contract with the Department of Health and Human Services' Food and Drug Administration to perform research titled "Quantifying Patients' Benefit-Risk Tradeoffs Associated with Percutaneous Revascularization Options for Peripheral Arterial Disease: A Collaborative Effort with the Rapid Pathways Patient Science Working Group." There is no set-aside designation. Major subcontractors include the University of...
This is a $494,060 Definitive Contract awarded by the Food and Drug Administration (FDA) to Drexel University, a private research university located in Philadelphia. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking research and development proposals to advance regulatory science. Specifically, the contract is for the development of "machine-learning based heterogeneous treatment effect models for prioritizing product-specific guidance development."...
This is a definitive federal contract awarded by the U.S. government to Duke University's Office of Research Administration Division as the prime contractor. The $3,252,484.82 contract is for biomedical research and exploratory development services, with no set-aside designation used. The contract appears to be part of a larger indefinite delivery/indefinite quantity (IDIQ) vehicle awarded to Duke by the Centers for Disease Control and Prevention (CDC) to provide clinical research and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Duke University for the production of a protein called A. CON-ENV-03 140CF. The contract has a firm fixed price of $149,839.00 and was awarded on May 10, 2012, with a completion date of June 8, 2012. The contract was not set aside for any specific socioeconomic designation. Duke University, through its Office of Research...